No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
TDOC250117P3000
- 0.00
- 0.000.00%
15min DelayClose Jan 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover0.00%IV70.62%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Teladoc Health Is Maintained at Outperform by RBC Capital
Oppenheimer Maintains Teladoc Health(TDOC.US) With Buy Rating, Cuts Target Price to $12
Teladoc Health Inc. (TDOC): GenAI Advancements Amid Bank of America's Price Target Adjustment
Oppenheimer Maintains Outperform on Teladoc Health, Lowers Price Target to $12
Teladoc Health Analyst Ratings
RBC Capital Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $12